John McLain, MD
Surgery · New Braunfels, TXNPI 1366857336
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.6%), education and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 47.0% of the total. Reporting peaked in 2024 at $4,161 and has fallen 93.2% since, to $283 in 2025.
Across 37 payments — averaging $222.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$4K
- Intuitive Surgical$4K
- Davol Inc.$267
- Integra Lifesciences Corporation$129
- Stryker$93
- Axonics, Inc.$50
- plus $49 from 3 others
What the payments were for
- Speaking & faculty fees$3,60044%
- Food & beverage$1,64820%
- Education$3,00036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 6 | $3,873 |
| Intuitive Surgical | 20 | $3,787 |
| Davol Inc. | 4 | $267 |
| Integra Lifesciences Corporation | 1 | $129 |
| Stryker | 1 | $93 |
| Axonics, Inc. | 2 | $50 |
| Baxter Healthcare | 1 | $23 |
| Vertex | 1 | $20 |
| Kerecis Limited | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$3,843
- DAVINCI XI$3,000
- INTEGRA$387
- Iovera$300
- Zilretta$300
- Phasix Mesh$233
- INTEGRA DERMAL REGENERATION TEMPLATE$129
- PRIMATRIX$129
- Da Vinci Surgical System$115
How this compares
$8,248 in reported general payments places this provider in the 70th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 30 | $37 |
Paid to pharmacies, not to this prescriber.
Other surgery in New Braunfels
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
- Nancy MarquezAustin$700K
- Sachin KukrejaDallas$640K
- Alejandro EsquivelAustin$631K
- Erik WilsonBellaire$610K
- Folahan AyoolaDenton$570K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.